Literature DB >> 33243829

Convolutional neural network to identify symptomatic Alzheimer's disease using multimodal retinal imaging.

C Ellis Wisely1, Dong Wang2, Ricardo Henao3, Dilraj S Grewal1, Atalie C Thompson1, Cason B Robbins1, Stephen P Yoon1, Srinath Soundararajan1, Bryce W Polascik1, James R Burke4, Andy Liu4, Lawrence Carin2, Sharon Fekrat5.   

Abstract

BACKGROUND/AIMS: To develop a convolutional neural network (CNN) to detect symptomatic Alzheimer's disease (AD) using a combination of multimodal retinal images and patient data.
METHODS: Colour maps of ganglion cell-inner plexiform layer (GC-IPL) thickness, superficial capillary plexus (SCP) optical coherence tomography angiography (OCTA) images, and ultra-widefield (UWF) colour and fundus autofluorescence (FAF) scanning laser ophthalmoscopy images were captured in individuals with AD or healthy cognition. A CNN to predict AD diagnosis was developed using multimodal retinal images, OCT and OCTA quantitative data, and patient data.
RESULTS: 284 eyes of 159 subjects (222 eyes from 123 cognitively healthy subjects and 62 eyes from 36 subjects with AD) were used to develop the model. Area under the receiving operating characteristic curve (AUC) values for predicted probability of AD for the independent test set varied by input used: UWF colour AUC 0.450 (95% CI 0.282, 0.592), OCTA SCP 0.582 (95% CI 0.440, 0.724), UWF FAF 0.618 (95% CI 0.462, 0.773), GC-IPL maps 0.809 (95% CI 0.700, 0.919). A model incorporating all images, quantitative data and patient data (AUC 0.836 (CI 0.729, 0.943)) performed similarly to models only incorporating all images (AUC 0.829 (95% CI 0.719, 0.939)). GC-IPL maps, quantitative data and patient data AUC 0.841 (95% CI 0.739, 0.943).
CONCLUSION: Our CNN used multimodal retinal images to successfully predict diagnosis of symptomatic AD in an independent test set. GC-IPL maps were the most useful single inputs for prediction. Models including only images performed similarly to models also including quantitative data and patient data. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diagnostic tests/investigation; imaging; retina

Mesh:

Year:  2020        PMID: 33243829     DOI: 10.1136/bjophthalmol-2020-317659

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  3 in total

1.  Longitudinal Analysis of the Retina and Choroid in Cognitively Normal Individuals at Higher Genetic Risk of Alzheimer Disease.

Authors:  Justin P Ma; Cason B Robbins; Jia Min Lee; Srinath Soundararajan; Sandra S Stinnett; Rupesh Agrawal; Brenda L Plassman; Eleonora M Lad; Heather Whitson; Dilraj S Grewal; Sharon Fekrat
Journal:  Ophthalmol Retina       Date:  2022-03-11

2.  AlzEye: longitudinal record-level linkage of ophthalmic imaging and hospital admissions of 353 157 patients in London, UK.

Authors:  Siegfried Karl Wagner; Fintan Hughes; Mario Cortina-Borja; Nikolas Pontikos; Robbert Struyven; Xiaoxuan Liu; Hugh Montgomery; Daniel C Alexander; Eric Topol; Steffen Erhard Petersen; Konstantinos Balaskas; Jack Hindley; Axel Petzold; Jugnoo S Rahi; Alastair K Denniston; Pearse A Keane
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

3.  Predicting Systemic Health Features from Retinal Fundus Images Using Transfer-Learning-Based Artificial Intelligence Models.

Authors:  Nergis C Khan; Chandrashan Perera; Eliot R Dow; Karen M Chen; Vinit B Mahajan; Prithvi Mruthyunjaya; Diana V Do; Theodore Leng; David Myung
Journal:  Diagnostics (Basel)       Date:  2022-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.